跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Neo-Pyrazon
Approved
STANDARD
Neo-Pyrazon
Amherst Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
852ee726a1deca2b
Company
Amherst Laboratories Inc.
Type
Standard
Approval Details
Approval Id
852ee726a1deca2b
Drug Approval Philippines Name
Neo-Pyrazon
Product Name
Neo-Pyrazon
Registration Number
DRP-2612
Brand Name
Neo-Pyrazon
Generic Name
Diclofenac sodium
Dosage Form
Enteric Film-Coated Tablet
Dosage Strength
50 mg
Manufacturer
Amherst Laboratories Inc.
Distributor
United Laboratories, Inc.
Issuance Date
28 May 2023
Expiry Date
25 June 2028
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
852ee726a1deca2b
Type
Standard
Back to Philippines FDA Approvals